BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Fundamental Analysis & Valuation

FRA:BRYN • US0846707026

Current stock price

404.8 EUR
+4.6 (+1.15%)
Last:

This BRYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. BRYN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BRYN was profitable.
  • BRYN had a positive operating cash flow in the past year.
  • BRYN had positive earnings in 4 of the past 5 years.
  • BRYN had a positive operating cash flow in each of the past 5 years.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B 40B 60B 80B

1.2 Ratios

  • The Return On Assets of BRYN (5.48%) is better than 84.62% of its industry peers.
  • Looking at the Return On Equity, with a value of 9.33%, BRYN is in the better half of the industry, outperforming 65.38% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.17%, BRYN is in line with its industry, outperforming 59.62% of the companies in the same industry.
  • BRYN had an Average Return On Invested Capital over the past 3 years of 4.29%. This is below the industry average of 9.16%.
Industry RankSector Rank
ROA 5.48%
ROE 9.33%
ROIC 4.17%
ROA(3y)7.4%
ROA(5y)5.83%
ROE(3y)13.39%
ROE(5y)10.63%
ROIC(3y)4.29%
ROIC(5y)3.99%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • BRYN has a Profit Margin of 18.03%. This is in the better half of the industry: BRYN outperforms 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of BRYN has remained more or less at the same level.
  • The Operating Margin of BRYN (15.63%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BRYN has grown nicely.
  • BRYN has a Gross Margin (24.75%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of BRYN has grown nicely.
Industry RankSector Rank
OM 15.63%
PM (TTM) 18.03%
GM 24.75%
OM growth 3Y5.77%
OM growth 5Y5.73%
PM growth 3YN/A
PM growth 5Y0.81%
GM growth 3Y5.1%
GM growth 5Y2.53%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BRYN.DE Health Analysis

2.1 Basic Checks

  • BRYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, BRYN has about the same amount of shares outstanding.
  • BRYN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T

2.2 Solvency

  • Based on the Altman-Z score of 1.37, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.37, BRYN is in line with its industry, outperforming 53.85% of the companies in the same industry.
  • The Debt to FCF ratio of BRYN is 5.15, which is a neutral value as it means it would take BRYN, 5.15 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.15, BRYN is in the better half of the industry, outperforming 63.46% of the companies in the same industry.
  • BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • BRYN has a better Debt to Equity ratio (0.18) than 71.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.15
Altman-Z 1.37
ROIC/WACC1.25
WACC3.32%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that BRYN should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.36, BRYN perfoms like the industry average, outperforming 55.77% of the companies in the same industry.
  • BRYN has a Quick Ratio of 1.09. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BRYN (1.09) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.09
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BRYN.DE Growth Analysis

3.1 Past

  • BRYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.25%.
  • BRYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.67% yearly.
  • Looking at the last year, BRYN shows a small growth in Revenue. The Revenue has grown by 0.00% in the last year.
  • The Revenue has been growing by 8.63% on average over the past years. This is quite good.
EPS 1Y (TTM)-6.25%
EPS 3Y13.85%
EPS 5Y17.67%
EPS Q2Q%-29.78%
Revenue 1Y (TTM)0%
Revenue growth 3Y7.14%
Revenue growth 5Y8.63%
Sales Q2Q%-0.72%

3.2 Future

  • Based on estimates for the next years, BRYN will show a small growth in Earnings Per Share. The EPS will grow by 4.50% on average per year.
  • Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 5.94% on average per year.
EPS Next Y4.44%
EPS Next 2Y3.97%
EPS Next 3Y6.18%
EPS Next 5Y4.5%
Revenue Next Year-4.7%
Revenue Next 2Y-0.81%
Revenue Next 3Y-0.49%
Revenue Next 5Y5.94%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

More info and screens

Find the best growth stocksShow best growing peers

9

4. BRYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • BRYN is valuated cheaply with a Price/Earnings ratio of 0.02.
  • BRYN's Price/Earnings ratio is rather cheap when compared to the industry. BRYN is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.35, BRYN is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
  • BRYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.23.
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BRYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRYN is cheaper than 90.38% of the companies in the same industry.
  • 100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.03
EV/EBITDA 1.04
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

  • BRYN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BRYN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0
PEG (5Y)0
EPS Next 2Y3.97%
EPS Next 3Y6.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRYN.DE Dividend Analysis

5.1 Amount

  • BRYN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRYN.DE Fundamentals: All Metrics, Ratios and Statistics

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (4/27/2026, 7:00:00 PM)

404.8

+4.6 (+1.15%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-02
Earnings (Next)05-04
Inst Owners30.99%
Inst Owner ChangeN/A
Ins Owners38.58%
Ins Owner ChangeN/A
Market Cap582.91M
Revenue(TTM)371.44B
Net Income(TTM)66.97B
Analysts44
Price Target438.86 (8.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.53%
Min EPS beat(2)-15.88%
Max EPS beat(2)4.81%
EPS beat(4)2
Avg EPS beat(4)-5.16%
Min EPS beat(4)-15.88%
Max EPS beat(4)4.81%
EPS beat(8)5
Avg EPS beat(8)5.49%
EPS beat(12)8
Avg EPS beat(12)6.31%
EPS beat(16)11
Avg EPS beat(16)6.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)2
Avg Revenue beat(8)-1.86%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)6
Avg Revenue beat(16)-0.79%
PT rev (1m)-0.93%
PT rev (3m)-2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.39%
EPS NY rev (1m)-2.68%
EPS NY rev (3m)-2.69%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-3.96%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-4.43%
Valuation
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
P/S 0
P/FCF 0.03
P/OCF 0.01
P/B 0
P/tB 0
EV/EBITDA 1.04
EPS(TTM)26410.8
EY6524.41%
EPS(NY)27583.65
Fwd EY6814.14%
FCF(TTM)14848.3
FCFY3668.06%
OCF(TTM)27256.6
OCFY6733.35%
SpS220241.82
BVpS425382.21
TBVpS355466
PEG (NY)0
PEG (5Y)0
Graham Number502773 (124102.82%)
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 9.33%
ROCE 5.14%
ROIC 4.17%
ROICexc 4.37%
ROICexgc 5.16%
OM 15.63%
PM (TTM) 18.03%
GM 24.75%
FCFM 6.74%
ROA(3y)7.4%
ROA(5y)5.83%
ROE(3y)13.39%
ROE(5y)10.63%
ROIC(3y)4.29%
ROIC(5y)3.99%
ROICexc(3y)4.49%
ROICexc(5y)4.21%
ROICexgc(3y)5.35%
ROICexgc(5y)5.06%
ROCE(3y)5.29%
ROCE(5y)4.92%
ROICexgc growth 3Y2.7%
ROICexgc growth 5Y6.05%
ROICexc growth 3Y3.93%
ROICexc growth 5Y7.05%
OM growth 3Y5.77%
OM growth 5Y5.73%
PM growth 3YN/A
PM growth 5Y0.81%
GM growth 3Y5.1%
GM growth 5Y2.53%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.15
Debt/EBITDA 1.8
Cap/Depr 155.29%
Cap/Sales 5.63%
Interest Coverage 11.39
Cash Conversion 64.28%
Profit Quality 37.39%
Current Ratio 1.36
Quick Ratio 1.09
Altman-Z 1.37
F-Score5
WACC3.32%
ROIC/WACC1.25
Cap/Depr(3y)152.78%
Cap/Depr(5y)144.82%
Cap/Sales(3y)5.36%
Cap/Sales(5y)5.2%
Profit Quality(3y)27.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.25%
EPS 3Y13.85%
EPS 5Y17.67%
EPS Q2Q%-29.78%
EPS Next Y4.44%
EPS Next 2Y3.97%
EPS Next 3Y6.18%
EPS Next 5Y4.5%
Revenue 1Y (TTM)0%
Revenue growth 3Y7.14%
Revenue growth 5Y8.63%
Sales Q2Q%-0.72%
Revenue Next Year-4.7%
Revenue Next 2Y-0.81%
Revenue Next 3Y-0.49%
Revenue Next 5Y5.94%
EBIT growth 1Y-4.75%
EBIT growth 3Y13.32%
EBIT growth 5Y14.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.58%
FCF growth 3Y4.59%
FCF growth 5Y-1.32%
OCF growth 1Y50.26%
OCF growth 3Y7.17%
OCF growth 5Y2.94%

BERKSHIRE HATHAWAY INC-CL B / BRYN.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.


What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

ChartMill assigns a valuation rating of 9 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.


How profitable is BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for BRYN stock?

The Earnings per Share (EPS) of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is expected to grow by 4.44% in the next year.